1. From the Division of Medical Oncology, Biostatistics, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA; the Department of Medicine, Brigham and Women's Hospital, Boston, MA; and the Division of Hematology/Oncology, Department of Medicine, The Children's Hospital, Harvard Medical School, Boston, MA, for the Dana-Farber ALL Consortium.